ADRB2 and colorectal cancer: Until now, two reports demonstrated that propranolol could completely abolished the chronic stress-promoted tumor growth in mice MM model and colorectal cancer model through a β-AR dependent pathway and might enhance the sunitinib anti-tumor effects via β-adrenoceptor-cAMP-PKA signaling pathway [29, 30].